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Abstract
We investigated the clinical and cost-effectiveness of using a locking versus non-locking
fixation plate in medial opening wedge high tibial osteotomy (HTO) for patients with medial
compartment knee osteoarthritis. Medical charts were retrospectively reviewed up to 12
months following HTO for 144 patients who received a locking plate and 105 patients who
received a non-locking plate. Surgeon notes provided the time to return to full weightbearing. Participants had completed the Knee injury and Osteoarthritis Outcome Score
(KOOS) preoperatively, six and 12 months postoperatively. Hospital and provincial
administrative databases provided direct and indirect cost data. Improvements in KOOS
scores were similar between groups. The locking plate was more expensive and therefore its
use was not cost-effective from the healthcare payer perspective. However, the locking plate
enabled statistically shorter time to return to full weight-bearing, translating to a faster return
to work, and therefore its use was cost-effective from the societal perspective.
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Chapter 1

1

Introduction

1.1 Background & Rationale
Osteoarthritis (OA) is a common degenerative health condition and a leading cause of
pain, disability and reduced quality of life in adult populations worldwide1. As a chronic
condition, the symptoms of the disease can persist for decades, resulting in substantial
economic burden to healthcare systems. In Canada, arthritis accounted for $6.4 billion of
direct and indirect healthcare costs in the year 2000, OA being responsible for the
majority of these costs2. These costs are expected to continue to grow with the aging
population and the rising rate of obesity3. Therefore, the identification of cost-effective
treatments for OA is of utmost concern for public health strategists2.
Osteoarthritis commonly involves the knee, with an estimated 250 million people
currently affected globally4. Although there is no known cure for knee OA, there are
several identified risk factors for knee OA progression that form the targets of various
interventions5–8. Varus alignment of the lower limb is a particularly strong risk factor for
the progression of knee OA due to its effect on loading the medial tibiofemoral
compartment9–13. Surgical and non-surgical treatments aimed at altering loads on the
medial tibiofemoral compartment are therefore common14–17.
Medial opening wedge high tibial osteotomy (HTO) is a surgical realignment procedure
for patients with varus malalignment and OA of the medial compartment of the
tibiofemoral joint15,18,19. The goals of HTO are to correct lower limb malalignment,
redistribute loads laterally across the knee to lessen the compressive force on the diseased
medial compartment, and thereby improve pain and function. The medial opening wedge
technique requires cutting into the medial proximal tibia, wedging the bone open to a
predetermined correction size to correct the malalignment, and securing the osteotomy
with a fixation device18,20,21.
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Adequate fixation of the osteotomy, typically achieved using an internal fixation plate, is
vital for bone healing and recovery during rehabilitation22,23, that involves progressive
weight-bearing using ambulatory aids (i.e. crutches, canes, etc.). The patient’s weightbearing status is progressed based on postoperative assessments of radiographic bone
healing and pain. The suggested duration of return to full weight-bearing after medial
opening wedge HTO ranges from 2 to 12 weeks, and highly depends on the type of
fixation used24–30.
HTO fixation plates are similar to those used for fracture fixation and can generally be
categorized as non-locking and locking. The mechanical principles are quite different for
non-locking and locking plates, providing distinct mechanical environments for bone
healing. Non-locking plates rely on bone-plate compression and high friction at the boneplate interface to provide fracture site stability31. At higher loads, however, non-locking
screws that are drilled into the bone can begin to loosen. This reduces bone-plate friction,
may render the plate unstable and increases the risk of complications such as hardware
failure, delayed union, non-union and loss of correction32. Locking plate designs address
mechanical issues with threaded fixed-angle screws or interference washers that control
the axial rotation between the screw and the plate, and eliminate screw-plate-bone
motion33. The mechanism does not rely on high friction at the bone-plate interface, but
rather maintains stability at the angular-stable screw-plate interface31. Locking plates also
convert shear stresses to compressive stresses, improving fixation since bone has a
stronger resistance to compressive stress compared to shear. The mechanical advantages
of locking plates provide stronger implant stability and resistance to higher load-bearing,
and are therefore suggested to be advantageous for healing after medial opening wedge
HTO23,34.
In vitro biomechanical studies have suggest that locking plates do provide greater
mechanical stability in response to compression and torsion35,36. Clinical studies suggest
locking plates maintain the osteotomy correction size better than non-locking plates37,38,
provide faster improvements in patient-important outcomes37,38, enable faster time to
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achieve bone healing37 and earlier return to full weight-bearing after surgery37,39,40.
Although results are mixed, some studies also suggest that the rates of delayed and nonunion22,38, loss of correction and hardware failure have decreased since the introduction
of locking plates 41.
The Arthrex ContourLock HTO Plate® (ContourLock) is a relatively new locking plate
designed to enable a precise fit proximally and distally on the tibia. The locking plate is
proposed to provide advantages when compared to the commonly used non-locking
Arthrex Puddu Plate® (Puddu). In-vitro biomechanical studies suggest the locking plate
provides greater stability under high physiological stress loading and cyclical testing
when compared to other locking and non-locking plates due to the wider distance
between its fixed-angle screws42,43. Although the greater stability is proposed to permit
faster recovery after surgery, there is currently no study evaluating clinical outcomes
after HTO using the plate.
The cost associated with using different HTO fixation plates is another important
consideration. Costs of HTO include direct (healthcare resources consumed and out-ofpocket expenses) and indirect (time and productivity losses) costs. If locking plates can
limit the number of postoperative complications that require revision surgery (i.e. nonunion), locking plates could provide direct cost savings. Additionally, if locking plates
enable quicker return to weight-bearing, patients could also return to work sooner, thus
financially benefiting society with indirect cost savings from productivity. Alternatively,
the cost of locking plates are substantially greater than non-locking plates because of
their more complex design and number of screws (typically six or more, compared to
four) used to achieve fixation. If clinical results are similar regardless of plate design then
the extra costs of locking plates may not be warranted. Furthermore, the relative
bulkiness of locking plates may cause irritation to the patients and require the plate to be
surgically removed40,44 which can increase direct costs associated with the procedure.
Importantly, the cost-effectiveness of different HTO fixation plate designs is currently
unknown and requires research. Therefore the purpose of the present study is to compare
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the clinical and cost-effectiveness of a locking plate (i.e., Arthrex ContourLock HTO
Plate®) versus a non-locking plate (i.e., Arthrex Puddu Plate®) used for medial opening
wedge HTO. Specific objective and hypotheses are listed below.
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1.2 Study Objectives and Hypotheses
1. To compare the time to return to full weight-bearing following medial opening
wedge HTO in patients receiving a locking versus non-locking fixation plate.
Hypothesis: Patients receiving the locking plate will return to full weight-bearing
sooner postoperatively.
2. To compare the change in patient-reported outcomes (Knee injury and
Osteoarthritis Outcome Score – KOOS) following a medial opening wedge HTO
in patients receiving a locking versus non-locking fixation plate.
Hypothesis: Patients receiving the locking plate will experience greater
improvements in patient-reported outcomes from baseline to 6 months after the
surgery.
3. To estimate the cost-effectiveness of a locking plate compared to a non-locking
plate, from the healthcare payer (Ministry of Health) and societal perspectives,
using change in KOOS total score at 12 months postoperative as the measure of
effectiveness.
Hypothesis: The locking plate will be cost-effective compared to the non-locking
plate from both the healthcare payer and societal perspectives.
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1.3 Review of Literature
1.3.1 Osteoarthritis
Osteoarthritis (OA) is the most common form of arthritis and is rapidly becoming one of
the most disabling health conditions worldwide4,45–47. It is a chronic musculoskeletal
disease that can affect single or multiple joints, and is characterized by localized joint
pain, functional limitations and diminished quality of life1,48. In Canada, there are more
than 4.4 million people (1 in 8) living with OA and this number is projected to double by
the year of 2040 due to the aging population and the obesity epidemic49.

1.3.1.1

Epidemiology

According to the 2013 Global Burden of Disease (GBD) study, the prevalence of OA has
grown 72% from the year 1990 with approximately 240 million people burdened by the
disease worldwide 4. The chronic nature of OA also makes it one of the fastest growing
health conditions in terms of disability46. It accounted for more than 17 million years
living with disability (YLDs) globally in 2010, a 64% increase from the year of 199050.
The World Health Organization (WHO) projects OA to become the fourth leading cause
of disability worldwide by the year 202051.
The disease is not isolated to a specific population group, but affects people of various
ethnic backgrounds and in different geographical locations worldwide52. Although OA
can be seen in people as young as 15 years of age, the majority of people affected by the
disease are older individuals3,53 with women being affected approximately twice as often
as men48.
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1.3.2 Knee Osteoarthritis
OA develops more frequently in the knee than any other weight-bearing joint in the
body54–56 with over 10% of the adult population currently affected by symptomatic knee
OA49. Due to the high loading demands on the joint, knee OA specifically is considered
one of the leading causes of physical disability worldwide57,58. The lifetime risk of
developing knee OA is estimated to be 45% (47% in women, 40% in men) with increased
odds seen in those who possess predisposing risk factors for the disease such as obesity
and malalignment, among others59.

1.3.2.1

Knee Anatomy

The knee is a complex synovial hinge joint between the patella, the distal femur and the
proximal tibia60. The bone surfaces are lined with hyaline (articular) cartilage which aids
in dissipating forces within the joint and limiting friction between bones. The cartilage
tissue is not innervated by pain receptors, nor is it well vascularized which limits the
tissue’s ability to repair itself61. Aside from the surfaces concealed by articular cartilage,
the inner lining of the joint is covered by a layer of connective tissue called the synovial
membrane, or synovium. Its cells secrete synovial fluid, a viscous substance which
reduces the level of friction within the joint space and provides nutrients to surrounding
tissues whose supply of blood is poor, such as the menisci. There is a meniscus for each
knee compartment (medial and lateral) between the articulating surfaces of the femur and
the tibia. Their function is to assist with force dissipation from within the joint, improve
knee joint stability and help lubricate the knee joint. Knee support is also maintained by
various muscles and ligaments. The surrounding networks of muscle are important for
assisting with shock absorption and initiation of movement about the knee. Ligaments are
arranged in a manner that provides stability mediolaterally (collateral ligaments) and
anteroposteriorly (cruciate ligaments) to the knee joint.
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1.3.2.2

Pathophysiology

Knee OA is a degenerative condition that affects the various tissues of the joint and is
considered a whole-joint disease62. It is characterized by the disruption of the natural
cartilage remodeling process, ultimately leading to the fibrillation and softening of the
articular cartilage and intensified degeneration of the tissue63. As cartilage continues to
breakdown, subchondral bone becomes exposed within the joint resulting in bone-onbone articulation. Continuous friction between exposed bone leads to the development of
osteophytes and subchondral cysts at the articulating bone extremities due to excessive
bone remodeling48,64. In later stages of the disease, the subchondral bone tissue will begin
to thicken and become sclerotic. Additionally, it is common to see inflammation of the
synovial lining of the joint46 as well of the overproduction of several proteolytic enzymes
and cytokines that have been shown to promote cartilage degradation and breakdown of
the extracellular matrix of the joint. These intra-articular changes and inflammatory
responses ultimately lead to loss of joint space, destabilization of the joint, abnormal joint
loading and a number of clinical symptoms for the affected individual.

1.3.2.3

Etiology

Similar to OA in other joints of the body, knee OA is a complex condition. The initial
onset of the disease can be idiopathic in nature, developing naturally over time as a result
of various interacting risk factors (known as primary OA), or can develop following
excessive or repetitive trauma to the knee joint such as ligament tears, cartilage impact,
etc. (known as secondary OA)47. There are still quite a few uncertainties that surround the
etiology of the disease. Knee OA is unpredictable in its method of initiation and its
progression, with some individuals exhibiting mild degeneration of the joint sustained
over an extended period of time, while others progress in disease severity very rapidly.
The medial compartment is the most commonly affected area of the joint when compared
to other compartments of the knee8,65–67. The disease does not affect the entire joint
uniformly.
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1.3.2.4

Risk Factors for Knee OA

As a disease whose onset and progression is quite variable, it is important to better
understand the multiple risk factors that predispose individuals to developing knee OA
and accelerate the progression of the disease. These risk factors can act systemically or
can be considered local by acting directly on the joint itself (Figure 1).
Systemic risk factors have a biochemical influence on the knee joint. These factors can
cause direct damage to the joint tissues or limit the tissue’s ability to repair itself after
being damaged, both of which make the affected individual susceptible to further injury.
Systemic risk factors that have been associated with development of knee OA and its
progression include age46,47, genetics46,47,62, gender6,46,62,68, overweight/obesity (BMI ≥
25)69,70, nutritional deficiencies71,72, inactivity72,73 and elevated bone mineral density74,75.
Local risk factors influence the joint mechanically. These factors are associated with
exposure to joint injury or excessive joint loading that leads to degeneration of tissues.
Local risk factors that have been associated with development of knee OA and its
progression include knee malalignment10,55,76,77, congenital deformities of the joint78,
previous injuries to the tissue components of the joint6,62,79,80, overweight/obesity (BMI ≥
25)81–83, occupation62,79,84, muscle weakness85,86, elevated peak knee adduction moment9–
11,87,88

, elevated knee adduction impulse89, and varus thrust90.

Although risk factors have been shown to independently promote knee OA disease
progression, the risks are intensified as individuals are exposed to multiple risk factors
simultaneously. For example, mechanical varus alignment of the lower limb has been
shown to increase the risk of medial compartment OA progression by a fourfold10,76 as a
result of increased mechanical axial loading on the joint past a normal physiological
range to maintain proper cartilage function. In overweight and obese individuals, the
sheer excess weight increases this level of mechanical loading of the medial compartment
leading to further articular cartilage breakdown. Various studies have suggested there is
an interaction between lower limb alignment and obesity5,7. Moreover, associated
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symptoms of pain resulting from knee OA can promote immobility and sedentary
lifestyles, risk factors for obesity, which can lead to further progression of OA as the
individual’s weight increases. For this reason, it is in the individual’s best interest to
tackle as many potential risk factors that are modifiable to minimize the risk of
developing knee OA or slow down disease progression.
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Figure 1: Schematic representation of the interacting systemic (biochemical) and
local (biomechanical) risk factors that are associated with the development of knee
OA and progression of the disease. Also presented are the radiographic and clinical
criteria used to diagnose knee OA according to Kellgren and Lawrence, 1957 and
Altman et al., 1986.
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1.3.2.4.1

Varus Alignment

Lower limb alignment is typically determined using full-limb standing hip-knee-ankle
(HKA) anteroposterior (AP) radiographs. The gold standard measure of lower limb
alignment is the mechanical axis angle (MAA), defined as the angle formed between the
line connecting the femoral head center of the hip and the knee joint center and the line
connecting the knee joint center and the ankle joint center91,92 (Figure 2). It has been
shown to provide excellent reliability when measured with digital software programs93,94.
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A

B

Figure 2: A) The mechanical axis angle (MAA) of the lower limb is measured as the
angle between the line connecting the center of the hip and knee joints and the line
connecting the center of the knee and ankle joints. B) The weight-bearing line
(WBL) is drawn from the center of the hip joint to the center of the ankle joint.
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Based on the MAA measure, lower limb alignment can be assessed to identify patients
with varus (“bow-legged”) or valgus (“knock-kneed”) alignment. Individuals with an
inward angulation of the distal segment of the lower limb (tibia and fibula) and a negative
MAA are considered varus aligned, while those with an outward angulation and a
positive MAA are considered valgus aligned. Many epidemiological studies suggest that
lower limb malalignment is an important risk factor for knee OA progression5,55,76,95,96
and that the direction of this malalignment will affect which compartment of the knee
joint is most affected. Medial compartment knee OA is most often seen in individuals
with varus alignment, whereas lateral compartment knee OA is more commonly seen in
individuals with valgus alignment55,76,97,98.
The role alignment plays in the degenerative process of medial knee OA is related to
increased loading of the knee joint10,96,99. The distribution of loading within the joint is
related to the lower limb weight-bearing line (WBL), a line drawn from the center of the
femoral head to the center of the ankle (Figure 2). Individuals who are neutrally aligned
will bear 75% of the overall knee load in the medial compartment while standing on one
leg91 with a WBL passing through the medial compartment of the joint. As alignment
steers away from neutral and the WBL is shifted medially, the load distribution within the
knee joint will undergo aberrant changes. Individuals with varus alignment will
experience an increase in medial compartment loading9,91,100. This in turn, will lead to a
heightened degree of articular cartilage degeneration. In fact, a longitudinal study found
that for every additional 1 degree of varus, patients will lose 17.7µl of femoral articular
cartilage on average annually, with similar losses seen in the tibial cartilage volume97.
Overall, the increase in compartmental loading associated with varus alignment promotes
progression of medial compartment knee OA. The additional loading intensifies medial
articular degeneration and loss which results in medial joint space narrowing, a further
degree of varus alignment and additional loading in the medial compartment, creating a
vicious cycle of medial compartment knee OA progression (Figure 3).
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alignment

Medial joint space
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Figure 3: The “vicious cycle” of medial compartment knee osteoarthritis. Varus
alignment leads to excess loading on the medial compartment, promotes articular
cartilage breakdown, narrowing of medial joint space and further malalignment of
the joint.
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1.3.2.4.2

Gait and Knee Osteoarthritis

For the general population, one of the most common daily activities performed is
walking, with thousands of steps taken per day101. Three-dimensional (3D) motion
analysis of gait kinematics and kinetics has been used extensively in the literature to
better understand biomechanical factors associated with knee OA. Specifically, authors
have investigated the role of the external knee adduction moment (KAM) (Figure 4) on
increased loading of the medial compartment10,102,103. During stance phase of gait,
individuals will generate a ground reaction force (GRF) vector that projects upwards and
medial to the knee joint’s center of rotation. The perpendicular line that connects the
GRF to the knee joint center is known as the lever arm and the product of this lever arm
and the GRF vector generates what is known as the external KAM. The external KAM
creates a torque force that causes the tibia to adduct in relation to the femur, which results
in greater compressive loading to the medial compartment of the joint. As the GRF is
projected more medially, the lever arm grows longer and thus, increases the magnitude of
the external KAM suggesting that the increase in external KAM is also related to
alignment. Halder at al. suggest that the magnitude of medial compartment loading
increases 5% for every 1 degree increase in varus while walking104.
Several studies have shown that the external KAM is strongly associated with
characteristics of knee OA such as knee pain in previously asymptomatic knees88 and
measures of OA disease severity87,105. It has also been proven to be a reliable, valid and
clinically meaningful proxy measure of medial compartment loading during gait9,106,107
and more importantly, a predictor for OA disease progression10,89. Thus, treatment
strategies have been geared towards decreasing the magnitude of external KAM during
walking in an attempt to slow disease progression.
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Figure 4: The external knee adduction moment (KAM) about the knee is the
product of the perpendicular distance between the knee joint center and the ground
reaction force (GRF) vector in the front plane, forming the lever arm, and the
magnitude of the GRF vector. Figure adapted from Perry J Gait Analysis: Normal
and Pathological Function 1992108.
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1.3.2.5

Diagnosis and Clinical Manifestations

Knee OA can develop in one or more of the three knee joint compartments: the medial
tibiofemoral joint, the lateral tibiofemoral joint or the patellofemoral joint. Clinicians will
use both clinical and radiographic assessment to diagnose patients with knee OA. Often,
clinical assessment follows the guidelines set by Altman et al.109, while radiographic
assessment follows the criteria set by Kellgren and Lawrence110 (Figure 1). According to
Altman et al., the required clinical criteria to diagnose a patient with knee OA includes
knee pain, as well as one of the following; crepitus (popping sound/sensation or
cracking) of the joint, over 50 years of age, or morning stiffness that lasts no longer than
30 minutes. For radiographic assessment, Kellgren and Lawrence developed a four point
joint degeneration rating scale (1 = mild OA, 4 = severe OA) to assess OA disease
severity in the knee joint by evaluating the presence or absence of osteophytic bone,
sclerosis of subchondral bone and whether marked joint space narrowing is present on
anteroposterior radiographs. Lateral and skyline radiographic views can also be helpful in
confirming compartment disease severity111.
Patients diagnosed with knee OA can exhibit a number of clinical symptoms which
include recurrent joint pain (frequently activity-induced and persistent), stiffness, and
swelling, reduced function, reduced range of motion, crepitus and deformity109,112. Often,
these symptoms will limit individuals and restrict participation in their daily activities113
and often makes them more dependent on others when it comes to walking, climbing
stairs and performing lower extremity activities. Therefore, it is of utmost importance to
identify treatment interventions that are geared towards minimizing pain, symptoms and
function for patients with knee OA.
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1.3.3 Management of medial compartment knee OA
Currently, there is no established cure for OA. However, a number of treatment
modalities are available to aid patients in the management of associated pain and
symptoms. Clinical guidelines outline non-surgical and surgical treatment interventions
for patients with symptomatic knee OA1,114. Available non-surgical interventions include
physiotherapy, pharmacotherapy, foot orthoses, bracing, lifestyle modifications and
activity management. These modalities typically target symptom management, but do not
alter joint anatomy and benefits are not considered to be permanent. Surgical
interventions include high tibial osteotomy (HTO), unicompartmental knee arthroplasty
(UKA) and total knee arthroplasty (TKA). These modalities physically alter joint bony
structures with permanent anatomical changes which modify risk factors that promote
knee OA disease progression such as knee malalignment. Ultimately, selection of
management method is decided upon mutually between the clinician and the patient
based on the patient’s personal characteristics, physical functional limitations, symptom
severity and the current level of disease severity.
For patients in earlier stages of the disease, clinicians typically attempt non-surgical
interventions before opting for surgery. However, patients who are at more progressed
stages of the disease often display substantial mobility restrictions, severe pain, decreases
in quality of life and severe degenerative changes in a single or multiple compartments of
the knee warranting a referral to an orthopaedic surgeon. The surgeon may recommend a
UKA or a TKA to replace the articular components of the joint or the surgeon may
recommend a HTO to correct malalignment of the lower limb, a risk factor for
progression of OA, while preserving the components of the joint. All three surgical
procedures have shown evidence of long-term benefits for pain management, improved
quality of life and mobility, but differ in terms of recovery time, invasiveness, potential
adverse events, limitations in activity participation following surgery and costs associated
with the procedures115–119. Thus, selection of the appropriate surgical intervention must
be done carefully in order to maximize the probability of successful outcomes following
surgery.
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1.3.4 Medial Opening Wedge High Tibial Osteotomy
Medial opening-wedge high tibial osteotomy is a surgical treatment for patients with
varus alignment of the lower limb and medial compartment knee OA15,19,20,120. The
procedure corrects knee malalignment by shifting the weight-bearing load of the joint
laterally to a more neutral position (usually slight valgus) and away from the affected
portion of the knee (Figure 5) 121. The redistribution of load decreases the magnitude of
both static (standing) and dynamic (during walking) loading in the medial compartment
with the goal of relieving patient symptoms and slowing the progression of the
disease95,122.
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A

B

Figure 5: Patient radiographs (A) before and (B) 12 months after HTO surgery. The
yellow lines provide an estimate of the weight-bearing line (WBL) to display the
shift to a more neutral position.
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1.3.4.1

Preoperative Assessment

Similar to consideration in other surgical procedures, surgeons take a thorough patient
history that identifies previous lower limb injuries or comorbidities that would
contraindicate the patient from undergoing surgery and help ensure patient compliance
during the post-operative period. A physical examination is then conducted to identify
ligamentous instabilities of the joint and to provide additional information to aid the
surgeon in establishing an appropriate treatment plan. Previous authors suggest the
surgery is ideally performed on healthy young, active patients, where the level of joint
degeneration is isolated to the medial compartment with associated varus alignment as
determined by the mechanical axis angle19,111,121. It is usually recommended to patients
whose activities of daily living are typically more physically demanding. Inactive patients
with tricompartmental disease, have complaints of rest/ night pain and those who are
above 60 years of age may be better suited for a TKA121. Appropriate patient selection is
considered crucial to maximize the likelihood that the procedure will be successful120.
Ideal patient criteria for medial opening wedge HTO is presented in Table 1.

Table 1: Ideal patient criteria for a medial opening wedge HTO.
Varus deformity of the lower limb
Pronounced degeneration in the medial compartment of the
tibiofemoral joint
Moderate to high activity levels
Younger than 60 years of age
A certain degree of pain tolerance
Symptoms of instability are not considered a contra-indication
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Radiographic assessment is considered an important component for preoperative
planning20,120 with full-limb standing anteroposterior (AP) radiographs111,123. Radiographs
are used to determine the patient’s MAA and anatomical axes of the femur and tibia, as
well as identifying the degree of arthritic joint degeneration in both the medial and lateral
compartments of the joint. Ultimately, the AP radiographs are used to calculate the
suggested degree of surgical correction for the procedure. Using the technique described
by Dudgale et al., the desired correction has the WBL shifting laterally to a maximum
position of 62.5% of the medial-to-lateral tibial plateau width, otherwise known as the
“Fujisawa point” 124.

1.3.4.2

Surgical Procedure

The classic technique for a medial opening wedge HTO has previously been described by
Amendola and Fowler20,120. First, a guide pin is drilled medially into the proximal tibia at
an angle approximately 3cm below the medial joint line. An oscillating saw is then used
to make surgical cuts medially, anteriorly and posteriorly into the proximal tibia where
both flexible and rigid osteotomes are used to complete the osteotomy and open the
wedge to a predetermined correction size. Once achieved, the proximal and distal
portions of the bone are fixed with an internal fixation plate using both cancellous and
cortical screws. Bone graft or a synthetic substitute is typically used to fill in the wedge
space for corrections larger than 7.5mm to assist with the bone healing process20,125. The
surgery is done under fluoroscopic control to ensure that the desired correction is
accurately achieved and to avoid breaching the lateral tibial cortex when making the cut.
Often, surgeons will also perform knee arthroscopy preceding the HTO to investigate OA
severity in both the medial and lateral compartments of the tibiofemoral joint. The degree
of degeneration in the lateral compartment is important to consider as shifting the loading
from the affected medial compartment to a lateral compartment that is equally as
degenerated may affect the success or longevity of the procedure. In such cases, surgeons
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must decide whether proceeding with the HTO is in the best interest for the patient.
Arthroscopy also allows a full visual inspection of the joint entirely to examine the
overall knee condition and to surgically treat unstable chondral or meniscal tissue if the
surgeon feels that it is indicated120.
Following surgery, patients are monitored during their rehabilitation and given early joint
exercises. These exercises are geared towards retraining patient gait, improving their
range of motion, managing pain and improving overall function. Patients undergo a
progressive returning to weight-bearing protocol based on evidence of radiographic bone
healing and subsidized pain.

1.3.4.3

Benefits of Medial Opening Wedge HTO

The most common surgical methods of HTO reported in the literature are the medial
opening wedge HTO and the lateral closing wedge HTO. Between these techniques,
medial opening wedge HTO has grown in popularity over the last few years126. The
method easily allows simultaneous bi-planar correction of the frontal and sagittal planes
to correct limb alignment. The ability to increase the wedge opening gradually to the
desired correction also allows for a more precise adjustment in both the frontal and
sagittal planes and makes it easier to achieve smaller corrections (< 5 degrees) than in a
lateral closing wedge HTO20. Moreover, the lateral closing wedge HTO requires two cuts
to be made in the bone which can make it difficult to achieve the proper correction size
and to form opposing bone surfaces that easily articulate to facilitate bone healing127.
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1.3.4.4

Medial Opening Wedge HTO Success

Many studies have shown that medial opening wedge HTO is beneficial to the patient
both clinically and biomechanically. Measures of pain, symptoms, function and quality of
life have all been shown to improve significantly at one to five year follow-up
assessments after the procedure27,28,122,128–130. It has also been shown to reduce the level
of loading on the medial compartment of the knee joint by significantly decreasing the
degree of malalignment122,131 and reducing the external knee adduction moment during
ambulation28,95,122,128,131 as well as other relevant kinematic and kinetic measures such as
varus thrust90 that promote disease progression. Overall, medial opening wedge HTO is
suggested to be a successful procedure with survival rates reported as high as 98% after
five years132, 90% after ten years133 and 71% after 15 years132 following the HTO.
Despite the many benefits of HTO, there are a number of complications associated with
the surgery. Reports of surgical complications vary between authors, ranging from 1% to
45% of cases24,126,134–139. The most frequently reported are lateral cortex hinge fractures,
hardware failure often resulting in loss of correction, delayed and non-union of the bone
(insufficient healing of the fracture site after a given time lapse) and hardware failure.
However, many authors suggest that the rate of complication is dependent on the type of
internal fixation used for the procedure37,38,126,134,140,141.

1.3.4.5

Weight-bearing and Return to Work after HTO

Postoperative care following medial opening wedge HTO typically involves a 2 week
period of toe-touch or feather weight -bearing with limb stabilization from a tracker
brace, followed by a progressive increase in weight-bearing to the surgeon’s discretion
based on radiographic healing of the bone and knee pain. The typical progression would
have patients graduate to toe-touch or feather-touch weight-bearing, followed by
protective (or partial, progressive) weight-bearing with crutches, to weight-bearing as
tolerated and finally, full weight-bearing without crutches.
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The length of time for protected weight-bearing ranges between two and 12 weeks24–30,142.
A return to full weight-bearing without gait aid (i.e. crutches, cane, walker, etc.) after
HTO surgery is dependent on the ability of the bone to consolidate enough to safely bear
weight on the limb. This is a major concern for surgeons, as allowing patients to early
weight-bear after HTO has the potential to increase complication rates if the plate does
not provide enough stability. As a result, studies have shown that the return to weightbearing process can be related to the type of fixation hardware used for the HTO37.
Optimized stable implant designs are therefore essential to warrant a safe earlier return to
weight-bear.
Another important factor to consider associated with the time to return to weight-bearing
is the time to return to work following the HTO. Time lost from employment and leisure
accounts for an estimated 80% of the overall annual costs for OA in Canada143. It is
important for healthcare providers to target OA treatment interventions that minimize
these productivity losses to society and help reduce the overall OA burden worldwide.
Previous studies have reported that the time to return to work following medial opening
wedge HTO ranges between three to six months142,144–146. It is important that more stable
plate designs are developed to allow patients to return to weight-bearing earlier,
translating to a faster return to work which will benefit society as a whole.

1.3.4.6

Locking Plate vs. Non-Locking Plate Designs

Early studies suggest that an optimal balance between micro-motion and implant stability
is needed to promote osteotomy healing147,148 by ensuring that the plate is not too stiff
(suppresses micro-motion and healing149) but is stable enough to evade non-union of the
osteotomy site. Over the years, technological advancements have allowed manufacturers
to design fixation plates that provide the required components to optimize HTO success.
Fixation plates used in HTO can generally be divided into non-locking and locking plate
categories. Conventional non-locking plates were designed to provide stability to the
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osteotomy with resistance to various types of loading33. The force generated from the
axial load is countered by the normal force of the plate (i.e. the product of the friction
force between the plate and bone, and the force generated by screw torque) which forms a
shear stress at the bone-plate interface. As the screw torque or the friction coefficient
decreases however, bone-plate motion increases. Excessive motion results in mechanical
environment that discourages primary or secondary bone healing. Furthermore, frictional
forces that are overcome by axial loading rely on the axial stiffness of the screw most
distal to the plate to maintain stability. The lack of axial control in non-locking screws
forces it to be maintained by the bone at the bone-plate interface. Here, the bone is the
load-determining factor in maintaining stability under compressive loads. The high
mechanical shear stresses generated therefore leaves the bone vulnerable to failure under
compressive load or susceptible to absorption of the bone that results in screw loosening.
Since, locking plate designs have been developed to address the mechanical pitfalls of
conventional non-locking plates. Locking plates control the axial orientation of the
screws to the plate, which improves bone-plate-screw stability33. Locking screw-plate
constructs act as fixed-angle devices that provide stability maintenance without relying
on bone-plate friction and can convert shear stresses to compressive stresses when subject
to loading. This improves the stability of the fixation as bone has a high resistance to
compressive stress and a low tolerance for shear stress. The strength of the fixation also
combines the strength of all bone-screw interfaces, as opposed to relying on the axial
stiffness of a single screw (i.e. in non-locking plates), which further increases the stability
of the implant150. Additionally, threaded locking screws or interference washers provide
angular and axial stability that optimize the rigidity of the fixation and optimized strain
under loading conditions. The latter provides a favourable biological environment for
secondary bone healing with callus formation, important for fractures located in the
metaphysis (Schutz, 2003) such as the case in the proximal tibia after HTO. The lack of
frictional forces between the bone and plate also allows blood supply under the plate to
be preserved and is suggested to promote faster bone healing151.
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Although all fixation plate designs have the same goal of maintaining correction size and
promoting bone healing, the mechanical and biological benefits that locking plates
provide are suggested to optimize rehabilitation outcomes after HTO surgery 27,127,152.
Many studies have evaluated different plate designs through biomechanics and clinical
outcomes23,29,34–38,42,43,140,141,153,154. General conclusions suggest that locking plates provide
better stability for patients with a higher resistance to mechanical stresses35 and optimized
micro-motion at the osteotomy site23. Locking plates are also suggested to allow patients
to return to full weight-bearing and achieve consolidation of the osteotomy faster37,
improve clinical outcomes faster37,141, and reduce the cases of delayed and non-union22,38,
hardware failure41, loss of correction41,155 and post-surgical lateral cortex fractures38 than
using a non-locking plate.

1.3.5 The Arthrex ContourLock HTO Plate®
The Arthrex ContourLock HTO Plate® is a new titanium fixation device designed with a
locking construct (Figure 6), an anatomically curved body, a wider frame than previously
introduced locking plates and screws that diverge proximally. To date, no studies have
compared clinical outcomes between the Arthrex ContourLock HTO Plate® and other
more conventionally used plate designs. However, a few studies have examined the
biomechanical differences between the Arthrex ContourLock HTO Plate® and other
implants.
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Figure 6: A) The Arthrex ContourLock HTO Plate® design (Arthrex, Naples, FL)
possesses a wide frame which lengthens the distance between fixation screws and
provides additional stability. B) & C) Top and side views of the Arthrex
ContourLock HTO Plate® illustrate the anatomically curved body of the implant.
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Studies have shown that the Arthrex ContourLock HTO Plate® provides great stability
under static loading, similar to other implant designs (Tomofix sm, Tomofix std,
iBalance, Peek Power), while it provides superior stability under dynamic cyclic loading
conditions, likely as a result of a wider frame and larger distance between fixation
screws42,43. Although these studies suggest that the maximum forces at moment of failure
are considered too low to warrant full dynamic loading (full weight-bearing) immediately
after the surgery for all the plate designs studied, the maximum force at failure for the
Arthrex ContourLock HTO Plate® is almost twice as high as other designs, suggesting
that full dynamic loading may be achievable for patients much earlier and would require
less healing of the osteotomy site to safely begin weight-bearing. Furthermore, a study
using finite element modeling showed that at higher compressive loadings, the Arthrex
ContourLock HTO Plate® experiences low hardware stresses and small wedge
micromotion which can be beneficial for fracture site healing156.
Although there is currently only a small body of evidence to support the use of the
Arthrex ContourLock HTO Plate® design, the aforementioned biomechanical studies
suggest that the Arthrex ContourLock HTO Plate® is a great implant choice for patients
who require a strong, stable locking construct for an early return to weight-bearing
following the HTO surgery. A faster return to full weight-bearing could translate to faster
improvements in clinical outcomes relating to pain, symptoms and quality of life for the
patient, as well as faster returns to daily activity and sport. In turn, patients could return
to work much earlier, which would provide socioeconomically benefit by reducing losses
in productivity in the workforce.
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1.3.6 Health Economics
Healthcare costs are rising at an alarming rate. The current economic climate requires a
high level of accountability from budgetary decision-makers for expended healthcare
dollars157. As a result, decision-makers are seeking treatment interventions that provide
the best quality of care for patients while minimizing dollars spent for the intervention.
Programs are now requesting evidence-based research to support the economic efficiency
of treatments to better judge the value for their money158.

1.3.6.1

Economic Evaluation

Economic evaluation provides a framework to compare clinical and cost data
simultaneously between competing interventions to assess value for money159. In Canada,
along with many other countries, economic analyses are a requirement for manufacturers
wishing to make their products available as treatment options with Ontario’s Health
Insurance Plan160. They are also a useful evaluative tool for decision-makers operating on
a given budget in order to make choices concerning the deployment of finances for
maximum health benefit.

1.3.6.2

Economic Burden of Osteoarthritis

Symptoms of OA typically do not resolve, and are associated with chronic pain that can
persist for decades, resulting in a substantial number of health-care visits over a lifetime,
which poses a large economic burden on healthcare systems. In industrialized countries
such as Canada, the US, UK, Australia and France, OA accounts for anywhere between 1
and 2.5% of the country’s gross national product161. In Canada alone, there is an average
annual cost of $12,200 ($CAN) per patient with OA143 with the annual economic burden
of OA estimated to increase to $405 billion dollars by 202049. As the burden of OA
continues to grow around the world, health care systems are in critical need of identifying
treatment interventions that limit OA progression at a minimal cost.

32

1.3.6.2.1

Cost-Effectiveness of Medial Opening Wedge HTO

Medial opening wedge HTO is a procedure that has been shown to benefit patients with
varus alignment and medial compartment knee OA both clinically and biomechanically
however, economic evaluation of the HTO procedure is an evolving area of research.
Studies are beginning to examine the economic impact of medial opening wedge HTO in
comparison to alternative treatment methods.
The first study to evaluate the cost-utility of HTO concluded that UKA is a more costeffective treatment method for medial compartment knee OA than HTO162 (Brown,
2010). A study that soon followed found results favoring the KineSpring® Knee Implant
System (an implantable load absorber)163. However, the authors from this study claim to
report an ICER when the values reported are in fact average cost-effectiveness ratios
(ACERs). This incorrect use of terminology can lead to misinterpretation of results164 and
inaccurate conclusions.
More recently, two studies have investigated the cost-utility of HTO compared to both
UKA and total knee arthroplasty (TKA) for younger patients with medial compartment
knee OA118,119. According to the results of these studies, HTO is the most cost-effective
treatment for patients below 60 years of age and the authors strongly support the use of
HTO as a first line treatment method for this younger patient population.
The aforementioned studies provide some evidence to suggest that HTO is a costeffective treatment intervention for patients who are varus aligned and with medial
compartment knee OA. However, no studies have been conducted to compare economic
impact of using different internal hardware devices when performing a medial opening
wedge HTO surgery. Locking plates have been suggested to provide functional and
patient-important benefits when compared to non-locking plates for medial opening
wedge HTO35,36,43 and are thought to reduce the number of post-operative complications
(i.e. non-union) that can result in revision surgery37,38,141. Patients are also expected to
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return to full weight-bearing sooner, and therefore productivity losses may be lessened by
allowing patients to return to work sooner. In both cases, costs associated with the
surgery can be minimized. However, locking plates and screws are generally more
expensive than non-locking designs, and the bulkiness of locking plates can be irritating
to the patient requiring surgical plate removal29,40,44 further increasing the costs
associated with the procedure. Cost-effectiveness analysis is therefore warranted to
justify using locking plates for medial opening wedge HTO.
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Chapter 2

2

Methods

2.1 Study Design
We conducted a retrospective analysis using prospectively collected data from patients
who had undergone medial opening wedge HTO at the Fowler Kennedy Sport Medicine
Clinic between July 2005 and June 2015, performed by one fellowship-trained
orthopaedic surgeon (JRG). All surgeries were completed using either a locking (Arthrex
ContourLock HTO Plate®) or a non-locking (Arthrex Puddu Plate®) internal fixation
plate. Patients at earlier time points of the study received the non-locking plate.
Availability of the locking plate in 2009 resulted in a shift in clinical practice where most
patients received the locking plate. The study was approved by the University of Western
Ontario’s Research Ethics Board for Health Sciences Research Involving Human
Subjects. All patients had provided informed consent prior to study enrollment to have
their data entered into a research database.

2.2 Eligibility Criteria
We included patients who underwent a medial opening wedge HTO for mechanical varus
alignment and had been diagnosed with knee OA according to the American College of
Rheumatology classification criteria109 affecting primarily the medial compartment of the
tibiofemoral joint. We did not exclude patients with evidence of lateral compartment
knee OA as long as the patient’s symptoms and radiographic severity of OA was more
pronounced in the medial compartment. We excluded patients who had a combined HTO
and anterior cruciate ligament (ACL) reconstruction, as well as those who received a
bilateral HTO. We also excluded patients that underwent a revision ACL reconstruction
surgery on the same limb or an HTO on the contralateral limb within 12 months
following surgery.
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2.3 Intervention
2.3.1 Operative Procedure
Preoperative hip-knee-ankle full-limb standing anteroposterior radiographic views were
used to calculate the desired correction size for the osteotomy using the method described
by Dugdale et al.124 This technique suggests a shift in the weight-bearing line to 62.5% of
the medial-to-lateral tibial plateau width. Other considerations for preoperative
templating were the condition of the articular cartilage in the lateral compartment and the
degree of correction required to achieve neutral alignment.
The HTO was performed using a medial opening wedge technique similar to the
procedure described by Fowler et al.20 Fluoroscopy was used to insert a guide pin and
osteotomes, both flexible and rigid, were used to perform the osteotomy. Once the tibia
was opened to the desired width, fluoroscopy was again used to confirm correction size
and limb alignment. If necessary, adjustments were made to the posterior tibial slope to
provide address sagittal instability. One of two plate designs was used as an internal
implant: a 4-hole Arthrex Puddu Plate® non-locking plate (Arthrex, Naples, FL, USA) or
an Arthrex ContourLock HTO Plate® locking plate (Arthrex, Naples, FL, USA). Cortical
and cancellous bone screws were used to fixate the osteotomy both proximally and
distally and confirmed using fluoroscopy. For corrections larger than 7.5mm, cancellous
bone allograft was used to fill in the osteotomy gap.

2.3.2 Post-operative Care
Following surgery, the operative limb was placed in a hinged knee brace. At this time,
patients were instructed to feather-touch weight-bear (WB) with the assistance of
crutches for a minimum of two weeks. Once the patient showed clinical and radiographic
evidence of osteotomy healing, they progressed to protective WB.The decision to
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progress the weight-bearing status of the patient during rehabilition was decided by the
surgeon using radiographic evidence of osteotomy healing (i.e. the extent of
consolidation on x-ray), perceived stability of the fixation device and the level of pain or
discomfort reported by the patient during ambulation.
Patients were also given a progressive rehabilitation protocol to allow them to reestablish full range of motion, strength and function, in addition to reducing swelling, and
avoiding joint contracture and muscle atrophy from disuse. Patients began this program at
three weeks postoperative with lighter exercises and progressed in exercise difficulty
until they exhibited a normal gait pattern at the discretion of the physiotherapist. All
patients followed the same rehabilitation protocol with slight modifications if deemed
necessary.
All patients returned to clinic for a follow-up visit with the surgeon at two and six weeks
and three, six and 12 months after surgery. Patients who experienced intraoperative or
post-operative complications (i.e. infection, delayed union, etc.) were reviewed as
needed.

2.4 Radiographic Assessment
A full-limb standing digital radiograph of the lower limb was obtained for each patient at
baseline, three, six and 12 months following surgery. Patients stood with patellae
centered over their femoral condyles with feet pointed straight ahead. The position
controls for effects of foot rotation on alignment measures that could result in inaccurate
frontal plane images165. Additional imaging was taken for patients who displayed delayed
bone healing and/or suspected complication to monitor consolidation more closely.
Baseline radiographs were assessed using a customized computer software program
(HTO Pro; Wolf Orthopaedic Biomechanics Laboratory, London, Ontario, Canada)93.
Anteroposterior radiographs were measured to obtain the preoperative mechanical axis
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angle (MAA) and to assess OA severity in both the medial and lateral tibiofemoral
compartments. The MAA was defined as the angle generated between the mechanical
axis of the femur and the mechanical axis of the tibia91,166. In other words, it is the angle
formed by the lines connecting the center of the hip to center of the knee, and the center
of the knee to the center of the ankle. The center of the hip was characterized as the
center of a circular outline positioned over the femoral head. The center of the knee was
characterized as the midpoint of a line drawn between the peaks of the tibial spines,
extrapolated inferiorly to the surface of the intercondylar eminence. The center of the
ankle was characterized as the midpoint between the fibula and tibia at the height of the
tibial plafond. A negative MAA value indicated varus alignment. Previous studies
conducted in our lab have shown excellent reliability for the MAA when using the
HTOPro program (ICC2,1 = 0.97)93. Joint degeneration in the medial and lateral
compartments of the tibiofemoral joint was measured using the Kellgren-Lawrence rating
scale110. Although the reliability of reporting the Kellgren-Lawrence grade using HTOPro
has not yet been reported, evaluators were given original atlases of individual
radiographic features for Kellgren-Lawrence grading of knee OA. These guidelines have
proven to be reliable in measuring the severity of knee OA.

2.5 Outcome Measures
2.5.1 Return to full weight-bearing
We defined time to return to full weight-bearing as the time to discontinuation of gait aid
use (i.e. crutches, cane, or walker), as documented in the medical record. A single
reviewer (CAP) reviewed patient clinic follow-up reports from each follow up visit time
point up to 12 months following the HTO. Identified weight-bearing status terms
included non-weight-bearing, toe-touch (or touch-down, feather-touch) weight-bearing,
partial (or progressive, protective) weight-bearing, weight-bearing as tolerated and full
weight-bearing. Discontinuation of gait aid use (i.e. crutch, cane, or walker) was outlined
as surgeon instruction to wean off of crutches (or slowly wean off) or a report that the
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patient was ambulating without the use of crutches (or other gait aid). A weight-bearing
status timeline was created for each patient to determine the total time it took for each
patient to return to full weight-bearing without use of a gait aid. The total time to return
to weight-bearing was expressed in weeks.
If the time to return to full weight-bearing was specified by the surgeon, the time from
surgery to that appointment date was attributed as the total time to return to weightbearing for the patient. For patients whose reports did not explicitly provide a value in
weeks, we made assumptions to determine total return to weight-bearing time. Patients
were given a time to return to full weight-bearing one week past the date of the follow-up
visit if they were instructed to wean off of their crutches and were fully weight-bearing
by their next appointment. Similarly, patients instructed to slowly wean off crutches were
attributed a time to return to weight-bearing two weeks later than the date of the followup visit. A patient who was described as having already been off crutches was attributed a
return to weight-bearing time one week earlier than said appointment as a conservative
measure. If the surgeon specified exactly how many weeks earlier that they were off
crutches, that value was assigned to the patient.
In cases where the patient missed an appointment visit and the time to return to weightbearing was unclear, a conservative measure of worst possible outcome was attributed to
that patient. For example, if a patient was still on crutches at 10 weeks, was not seen at 3
months, but was off crutches at a 4 month appointment visit, the given outcome value
was one week earlier than the 4 month appointment date (i.e. 16 weeks).

2.5.2 Knee injury and Osteoarthritis Outcome Score
The Knee injury and Osteoarthritis Outcome Score (KOOS) is a 42-item selfadministered knee and OA-specific questionnaire that addresses five domains of health:
pain (9 items), other symptoms (7 items), function during activities of daily living (17
items), function during sport and recreational activities (5 items), and quality of life
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related to the knee (4 items). The tool uses a five-point ordinal scale for each item and
generates a standardized mean value score to represent each of the five domains ranging
from 0 (worst outcome) to 100 (best outcome). The KOOS has been shown to exhibit
excellent test-retest reliability in each domain (range 0.75-0.93), face validity, construct
validity and responsiveness to change for individuals with knee OA and ligamentous
injuries167,168. A change of ten points in a given KOOS domain is considered to be
clinically meaningful169.

2.5.3 Cost
2.5.3.1

Surgical Costs

All direct costs associated with the HTO procedure were reported using the average
procedure cost from the Ontario Case Costing Initiative170 in addition to costs associated
with any additional surgeries (e.g. revisions, hardware removals, irrigation and
debridement for infection). These costs included operating room (OR) costs, equipment
used, and other medical tests performed during the procedure, as well as the total length
of stay in the hospital (outpatient or inpatient) following surgery. Surgeon and
anaesthesiologist billing fees were obtained through the Ontario Ministry of Health
Schedule of Benefits171. The individual costs for the locking (Arthrex ContourLock HTO
Plate®) and non-locking (Arthrex Puddu Plate®) plates and their associated fixation
screws were obtained from our hospital’s cost report data.

2.5.3.2

Healthcare Resource Use

To account for possible postoperative complications, we recorded any additional
healthcare resource use for 12 months following the HTO surgery by reviewing patient
clinic charts and electronic hospital records. All clinic consultations, follow-up visits,
emergency room visits and hospitalization, diagnostic imaging and laboratory tests
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performed and additional procedures performed for postoperative complications were
recorded. Costs were attributed using the Ontario Ministry of Health Schedule of
Benefits171.
Additionally, we recorded patient time to return to work. The time to return to work was
defined as the time loss of employment, retirement or homemaking following surgery.
The total time was determined in one of two ways. First, if patients returned to the clinic
for a follow up visit during the study period, they were asked to indicate their
employment status at the time of surgery, time off work from paid employment (or
retirement, homemaking activities, etc.) as a result of the HTO, change in employment
status (i.e. modified or restricted duties), and level of activity of employment. If patients
did not return to the clinic during the study period, we reviewed the surgeon dictated
clinic follow-up reports up to 12 months following the HTO to identify the patient’s
occupation and references of date to return to employment. The total time was reported as
either below 3 months (with specification of total time), 3-4 months, 5-6 months, 7-8
months, more than 8 months (with specification of total time) or “I did not return to
work”.
The 2015 average Canadian wage reported by Statistics Canada was used to account for
time off employment172. We assigned the current value of minimum wage in Ontario to
account for time off for patients who were retired, or who lost time from home making
activities.
We estimated the total cost for each individual patient over the study period. All costs
were reported in 2016 Canadian dollars.
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2.6 Data Analysis
We used descriptive statistics to describe the demographic and clinical characteristics for
each group. We report means and standard deviation (SD) for all continuous measures
(age, height, mass, body mass index (BMI), mechanical axis angle (MAA)), and
frequencies and proportions for categorical variables (sex, Kellgren-Lawrence grade and
American Society of Anesthesiologists (ASA)) (Table1). All statistical measurements
were performed using the Statistical Package for the Social Sciences (SPSS) version 23.0
(IBM SPSS Statistics v 23; IBM Corp, Armonk, New York, USA).

2.6.1 Objective 1
We conducted an independent t-test to compare the mean between group difference in
time to return to full weight-bearing with 95% confidence intervals around the estimate.

2.6.2 Objective 2
We calculated KOOS change scores from baseline to six months after surgery and
presented the mean and standard deviation (SD) by group for the total KOOS and for
each KOOS subdomain. We used the six-month time point as our outcome measure since
stability differences between the plates could affect patient-important outcomes shorter
term; however, most patients have fully recovered regardless of the plate used by 12
months after surgery. We compared the mean between group difference in change score
using an independent t-test and report 95% confidence intervals around the estimates.
For objectives 1 and 2, we tested the assumptions for independent samples t-test which
include homogeneity of variance, random independent samples, and normality. Normality
was tested by plotting a histogram for each outcome and all graphs were assessed for
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kurtosis and skewness. A Mann-Whitney U non-parametric test was performed if the
assumption of normality was not met.

2.6.3 Objective 3
2.6.3.1

Economic Analysis

We conducted a cost-effectiveness analysis from the healthcare payer and societal
perspectives. The healthcare payer perspective includes the direct costs from healthcare
resources consumed including the HTO surgery, any additional procedures (e.g. revision
surgeries), diagnostic testing and inpatient hospitalizations. The societal perspective
includes these same costs along with out-of-pocket patient costs (e.g. hyaluronic acid or
corticosteroid injections) and indirect costs such as time off employment, retirement and
homemaking activities as a result of the surgery. To capture all costs associated with
return to work and additional surgical procedures, we included all costs up to 12 months
following surgery and used the KOOS total change score from baseline to 12 months
postoperative as our effectiveness measure.

2.6.3.2

Incremental Cost-Effectiveness Ratio

We calculated the incremental cost-effectiveness ratio (ICER) to consider the value of
using the locking plate. The ICER is defined as the ratio between the incremental cost
and the incremental effect (change in KOOS).

2.6.3.3

Net Benefit Regression

We also estimated the cost-effectiveness of the locking plate using the net benefit
regression (NBR) framework173, a statistical tool that considers both the incremental cost
and effect of an intervention in addition to the maximum acceptable amount one is
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willing-to-pay (WTP) in order to achieve one additional unit improvement in effect. In
this framework, an intervention is deemed more cost-effective than the existing treatment
if:
𝐼𝑁𝐵 = 𝑊𝑇𝑃 ∗    ∆𝐸 −    ∆𝐶   > 0

[1]

where INB represents the incremental net benefit, WTP is the willingness-to-pay value,
ΔE is the incremental effect and ΔC is the incremental cost.
We conducted two individual NBR models to evaluate from both the payer and societal
perspectives. The WTP values used varied between $0 and $2,000. The following
covariates were included in our models: age, sex, BMI, comorbidities and baseline MAA.
We tested the assumptions for multiple linear regression which include a linear
relationship between independent and dependent variables, multivariate normality,
limited multicollinearity, no auto-correlation and homoscedasticity. Linear relationships
were assessed with scatter plots. Multivariate normality was assessed by plotting
histograms and all graphs were assessed for kurtosis and skewness. Homoscedasticity
was assessed by plotting predicted values against the observed values and observing the
proximity of points to the prediction line.

2.6.3.4

Uncertainty

To characterize the statistical uncertainty, we presented 95% CIs around our estimates of
the incremental net benefit (INB) and with a cost-effectiveness acceptability curve
(CEAC)174. The CEAC provides a functional representation of probability that the
treatment is cost-effective at various WTP values.
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2.6.3.5

Sensitivity Analysis

We conducted one-way sensitivity analyses on the variables that were considered to have
the most uncertainty because of the assumptions required to calculate the cost: 1) the
dollar value for retired or home making time (ranging from $0 per hour to $11.25 per
hour); 2) adding seven weeks to the return to weight-bearing time for patients where we
were unable to collect a return to work time and using this value as their time to return to
work, as seven weeks was the mean time to return to work from return to full weightbearing in our sample; 3) combining the adjustments of sensitivity analyses 1 and 2.

2.6.4 Missing Data
We used Multiple Imputation methods to impute missing 6 and 12 month KOOS total
change score data. A pooled score was generated from 5 individual imputations to
provide a best estimate value. Covariates including age, sex, BMI, comorbidities,
baseline MAA and baseline total KOOS were used in the model to increase the accuracy
of the imputed values.
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Chapter 3

3

Results

3.1 Patient Flow
We screened 502 HTO procedures that were captured in our database. Of these, 249 met
the inclusion criteria and were included in the present analysis. From this sample, 144
patients underwent a medial opening wedge HTO using the locking plate, while 105
patients received the non-locking plate (Figure 7).
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Number of surgeries by JRG between
July 2005 and June 2015 (n = 502)

Excluded (n = 253)
Reasons for exclusion:

Included
(n = 249)

Combined HTO/ACL reconstruction (n = 112)
Contralateral HTO within 12 months (n = 60)
Alternative fixation plate (n = 32)
Lost to follow-up in first 6 months (n = 22)
Other HTO procedure performed (n = 21)
Staged ACL reconstruction within 6 months (n = 6)

Locking Plate
(Arthrex ContourLock HTO
Plate®, n = 144)

Non-locking Plate
(Arthrex Puddu Plate®,
n = 105)

Baseline (n = 144)

Baseline (n = 105)

6-month follow-up (n = 144)

6-month follow-up (n = 105)

12-month follow-up (n = 144)*

12-month follow-up (n = 105)*

Figure 7: Participant flow through the study. Asterisk represents a smaller sample size for the costeffectiveness analysis from the societal perspective (n = 106 locking plate, n = 58 non-locking plate).
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3.2 Demographics and Clinical Characteristics
Baseline demographics and clinical characteristics were similar between groups (Table
2). Patients were typically male, middle-aged and categorized as overweight from their
BMI. Patients were varus aligned as defined by their MAA and had large correction sizes.
Most had advanced osteoarthritic degeneration in the medial compartment of the
tibiofemoral joint, however, the degree of lateral compartment joint degeneration was
slightly higher in the locking plate group. According to the American Society of
Anesthesiologists (ASA) score, most patients were considered to have mild systemic
disease.
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Table 2 : Baseline demographics and clinical characteristics (n = 249)*.
Group 1:
Group 2:
Demographic/clinical characteristic
Locking Plate	
  
Non-locking Plate
(n = 144)
(n = 105)
Sex, no. (%)
Male
108 (75.0)
79 (75.2)
Age, years
48.9 ± 8.0
46.7 ± 8.6
Height, cm
175.6 ± 8.3
175.7 ± 9.0
Mass, kg
92.5 ± 15.3
91.0 ± 17.0
2
Body mass index (BMI), kg/m
30.1 ± 5.0
29.4 ± 4.4
Operative limb left, no. (%)
77 (53.5)
52 (49.5)
Mechanical axis angle, degrees a
-8.5 ± 2.8
-8.1 ± 3.4
Mean correction size ± SD (mm)
11.9 ± 2.7
12.3 ± 3.0
Medial Compartment K/L Grade, no. (%) b
1
11 (7.6)
9 (8.6)
2
48 (33.3)
28 (26.7)
3
61 (42.4)
42 (40.0)
4
21 (14.6)
23 (21.9)
b
Lateral Compartment K/L Grade, no. (%)
1
25 (17.4)
53 (50.5)
2
82 (56.9)
31 (29.5)
3
31 (21.5)
10 (9.5)
4
0 (0.0)
0 (0.0)
American Society of Anesthesiologists
score, no. (%) c
1
47 (32.6)
37 (35.2)
2
83 (57.6)
54 (51.4)
3
14 (9.7)
14 (13.3)
*Values are reported as means with standard deviations unless otherwise specified
a
A negative mechanical axis value indicates varus alignment
b
Kellgren-Lawrence (K/L) grade of osteoarthritis severity
c
American Society of Anesthesiologists physical status classification system: 1 = healthy, normal patient; 2
= patient with mild systemic disease; 3 = patient with severe systemic disease
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3.3 Surgical Characteristics
Diagnostic knee arthroscopy was performed on 246 (98.8%) patients. A tibial tubercle
osteotomy (TTO) was performed on 130 (52.2%) patients in order to maintain patellar
height175. Cancellous bone allograft was used to fill the osteotomy for 238 (95.6%)
patients. Substitute bone grafts used included: cancellous autograft for two patients,
demineralized bone matrix for one patient and OsteoSet bone graft for one patient. The
osteotomy was left unfilled in 7 cases (2.8%). Plate removal from a previous HTO on the
contralateral limb was performed on nine (3.6%) patients (3 non-locking, 6 locking)
during the procedure and removal of TTO hardware from a previous HTO was performed
on two (0.8%) patients (2 non-locking). The surgery was an inpatient procedure for most
cases (228 patients, 91.6%).
Slight between-group differences were seen in the number of concomitant tibial tubercle
osteotomy (TTO) surgeries performed (91 patients, 63% locking plate; 39 patients, 37%
non-locking plate), the number of outpatient cases (19 patients, 13% locking plate; 2
patients, 2% non-locking) and the number of osteotomies that were left unfilled, with no
bone graft (1 patients, 1% locking plate; 6 patients, 6% non-locking). These most likely
represent slight changes in clinical practice of JRG.
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3.4 Surgical and Post-operative Complications
A hematoma was noted in 13 cases. Deep infection was identified in three patients
requiring an irrigation and debridement surgical procedure to be performed. One patient
experienced isolated anterior compartment syndrome (likely related to combined TTO),
which was treated surgically with a fasciotomy. A pulmonary embolism was confirmed
for one patient with chest radiographs and was treated with thrombolytic medication. A
deep vein thrombosis (DVT) was documented for one patient through ultrasound and was
treated with an anticoagulant. Partial implant failure was document in the charts of 12
patients where ten patients had one broken screw and two patients had two broken
screws. A partial loss of correction was identified for one patient. One patient
experienced non-union of the osteotomy site that required a revision osteotomy surgery to
be performed. A total of 19 patients complained of irritation at site of osteotomy
following the surgery and had the hardware surgically removed within the first 12 months
postoperatively. No patients experienced neurovascular injuries or cardiac complications.
Adverse event rates are summarized in Table 3.

Table 3: Adverse event rates within first 12 months after HTO (n = 249).*
Complication
Hematoma
Deep infection
Compartment syndrome
Pulmonary embolism
Deep vein thrombosis
(documented)
Hardware failure
1 broken screw
2 broken screws
Partial loss of correction
Non-union/collapse
Hardware removal
Neurovascular injury
Cardiac complications

Group 1: Locking Plate
(n = 144)

Group 2: Non-locking Plate
(n = 105)

3 (2.1%)
3 (2.1%)
1 (0.7%)
1 (0.7%)

9 (8.6%)
0 (0.0%)
0 (0.0%)
0 (0.0%)

1 (0.7%)

0 (0.0%)

3 (2.1%)
1 (0.7%)
1 (0.7%)
0 (0.0%)
11 (8.3%)
0 (0.0%)
0 (0.0%)

7 (6.7%)
1 (1.0%)
0 (0.0%)
1 (1.0%)
8 (7.6%)
0 (0.0%)
0 (0.0%)

*Values are reported as frequencies with proportions
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3.5 Outcome Measures
3.5.1 Objective 1
There was a statistically significant difference between treatment groups in the time to
return to full weight-bearing with discontinuation of gait aid (mean difference 6.1 weeks;
95% CI 4.5, 7.6), with a faster return to weight-bearing for the locking plate group (Table
4, Figure 8).

3.5.2 Objective 2
Although the KOOS total change score and subdomain change scores were slightly
higher in the locking plate group from baseline to six months after surgery, no significant
between-group differences were found (Table 4, Figure 9). Large improvements were
seen for both groups from baseline to six months in the total KOOS and all subdomains,
above the minimal clinically important difference (MCID) of ten points176. Missing 6month data values were imputed for 17 patients in the locking plate group (11.8%) and 11
patients in the non-locking plate group (10.5%).
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Table 4: Time to return to weight-bearing and patient reported outcome measures
(KOOS) for all patients (n = 244)*.
Outcome
Time to return to WB
KOOS
Outcome
Time point
(range 0 –
100)
Pain
Baseline
6-month
Change Score a
Other
Baseline
Symptoms
6-month
Change Score a
ADL
Baseline
6-month
Change Score a
Sport and
Baseline
Recreation
6-month
Change Score a
Quality of life Baseline
6-month
Change Score a
KOOS Total
Baseline
6-month
Change Score a

Time (weeks)
Locking Plate
Non-locking Plate
(n = 144)
(n = 105)
10.9 ± 5.8
17.0 ± 6.5
Treatment Group
Locking Plate
(n = 144)

Non-locking Plate
(n = 105)

52.0 ± 19.9
70.1 ± 17.7
18.3 ± 20.7
49.9 ± 17.8
69.6 ± 16.5
18.0 ± 20.5
60.9 ± 21.0
77.8 ± 18.0
17.7 ± 22.5
29.1 ± 22.8
46.5 ± 24.1
17.6 ± 28.5
30.2 ± 19.8
49.0 ± 22.0
18.4 ± 23.5
50.9 ± 18.8
68.3 ± 16.9
17.9 ± 20.4

52.6 ± 18.5
68.5 ± 17.6
15.9 ± 20.6
52.8 ± 19.9
65.7 ± 20.5
15.4 ± 20.4
61.8 ± 19.8
74.2 ± 17.5
12.6 ± 20.3
28.0 ± 22.3
43.1 ± 24.2
14.5 ± 26.1
25.0 ± 30.1
43.1 ± 24.2
16.4 ± 22.2
50.3 ± 17.2
64.7 ± 17.1
14.4 ± 19.1

p-value
<0.01‡
Mean Difference c
(95% CI)

p-value

-2.4 (-8.1, 3.4)

0.42

-2.6 (-8.3, 3.1)

0.37

-5.0 (-11.1, 1.0)

0.10

-3.1 (-10.8, 4.5)

0.42

-2.0 (-8.4, 4.4)

0.55

-3.5 (-9.1, 2.0)

0.21

*Values are reported as means with standard deviations
a
The change in KOOS score between baseline and 6 months after surgery
b
A positive mean difference favors the locking plate treatment group
c
A negative mean difference favors the locking plate treatment group
† p < 0.05, ‡ p ≤ 0.001
Abbreviations: KOOS = Knee injury and Osteoarthritis Outcome Score, ADL = Activities of Daily Living,
CI = confidence interval, WB = weight-bearing
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ContourLock

Time to return to full weight-bearing (weeks)

Puddu
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0
Plate

Figure 8: Mean time to return to full weight-bearing with complete discontinuation
of gait aid use (in weeks with 95% confidence intervals) for patients undergoing a
medial opening wedge high tibial osteotomy with a locking or non-locking internal
fixation plate. Stars indicate a significant difference.
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Living
KOOS Domain

Quality
of life

Overall

Figure 9: Mean Knee injury and Osteoarthritis Outcome Score (KOOS) total and
subdomain change scores from baseline to six months postoperative (with 95%
confidence intervals) for patients undergoing a medial opening wedge high tibial
osteotomy with a locking or non-locking internal fixation plate.
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3.5.3 Objective 3
There was a statistically significant difference between groups in mean costs from the
healthcare payer perspective favoring the non-locking plate group (Table 5). A
statistically significant difference was also seen from the societal perspective, however
favoring the locking plate group. The mean between group difference in effect (KOOS
change score) was small and not statistically significant, but favored the locking plate
group. Missing 12-month data values were imputed for 19 patients in the locking plate
group (13.2%) and 12 patients in the non-locking plate group (11.4%).

3.5.3.1

ICER

The ICER was $472.00 per one point improvement in the total KOOS change score for
the healthcare payer perspective (Table 5), translating to an additional $4,720 per patient
for a clinically important improvement of ten KOOS points compared to patients who
receive a non-locking plate. The ICER was -$3892.63 for the societal perspective,
indicating a cost saving of $3892.63 per additional one point improvement in total KOOS
change score in favor of the locking plate group. The negative incremental cost and
positive incremental effect from the ICER suggest that, when incorporating indirect costs,
the locking plate costs less for a better outcome compared to the non-locking plate.

3.5.3.2

Net Benefit Regression

From the healthcare payer perspective, the incremental net benefit (INB) was negative for
WTP values <$1,000, indicating that the locking plate is not cost-effective compared to
the non-locking plate below this WTP threshold (Table 6). At a WTP ≥ $1,000, the
positive INB indicates that the locking plate is cost-effective compared to the non-locking
plate at this threshold. From a societal perspective, the INB was positive for all WTP
suggesting that the locking plate is cost-effective compared to the non-locking plate.
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3.5.3.2.1

Uncertainty

From the healthcare payer perspective, the 95% confidence intervals (CI) around our
estimate widen as WTP increases and at WTP values ≥$1,000, the lower bounds of the
95% CIs remain negative. The larger confidence intervals suggest a higher degree of
uncertainty surrounding the cost-effectiveness of the locking plate as one is willing to pay
more. From the societal perspective, the lower bounds of the CI remain positive up to a
WTP of $500, however become negative at values >$500 and these CIs continue to
widen as WTP increases also suggesting uncertainty.
To visually display this uncertainty, the probability of cost-effectiveness for the locking
plate is displayed on the cost-effectiveness acceptability curve (CEAC) (Figure 10). From
the healthcare payer perspective, the CEAC suggests that even at a WTP of $1,000 for a
one point improvement in total KOOS change score (i.e. $10,000 for a clinically
meaningful improvement), the probability that the locking plate is cost-effective is 50%
(Figure 10A). From a societal perspective, the CEAC suggests with 99% certainty that
the locking plate is cost-effective at a WTP value of $0 (Figure 10B). As WTP increases
however, this certainty slowly declines as a result of cost savings with minimal
improvement in effect (Fenwick, 2004).

Δ Effect
+1.60

Effect*,b
21.32

-812.26 (243.34)
-605.15 (654.95)
-398.05 (1236.74)
-190.94 (1833.28)
16.16 (2433.74)
223.26 (3035.80)
430.38 (3638.67)
637.48 (4242.00)
844.59 (4845.62)

WTP*

0
250
500
750
1000
1250
1500
1750
2000

-1291.6 to -332.9
-1895.4 to 685.1
-2834.5 to 2038.4
-3802.5 to 3420.6
-4778.4 to 4810.7
-5757.3 to 6203.9
-6737.9 to 7598.6
-7719.4 to 8994.3
-8701.4 to 10390.6

95% CI
<0.001‡
0.356
0.748
0.917
0.995
0.941
0.906
0.881
0.862

p-value

5232.19 (2127.32)
5599.82 (2324.64)
5967.46 (2761.42)
6335.09 (3345.13)
6702.72 (4012.16)
7070.35 (4727.36)
7437.98 (5471.88)
7805.61 (6235.22)
8173.24 (7011.24)

95% CI

ICER
-3892.63

ICER
+472.00

1029.9 to 9434.5
1007.8 to 10191.9
512.6 to 11422.3
-272.8 to 12943.0
-1222.8 to 14628.3
-2268.0 to 16408.7
-3371.1 to 18247.1
-4511.4 to 20122.6
-5676.6 to 22023.2

CI, p-value
(-6.1, 2.9),
0.49

CI, p-value
(-6.1, 2.9),
0.49

Societal**
Incremental net benefit

* WTP for a one-point improvement on the KOOS total change score from baseline to 12 months
** Incremental net benefit with standard error (SE)
a
A positive incremental net benefit favors the locking plate treatment group
† p < 0.05, ‡ p ≤ 0.001
Abbreviations: WTP = willingness-to-pay, CI = confidence interval

a

Healthcare payer**
Incremental net benefit

Table 6: Net benefit regression results.

a

Δ Effect
+1.60

Effect*,b
21.32
19.72

Non-locking
30123.09
19.72
*Values are reported as means
a
2016 Canadian dollars.
b
Total change Knee injury and Osteoarthritis Outcome Score (KOOS) between baseline and 12 months
† p < 0.05, ‡ p ≤ 0.001
Abbreviations: ICER = Incremental cost-effectiveness ratio, CI = confidence interval

Healthcare payer (n = 249, CL = 144, PUD = 105)
Plate
Cost*,a
Δ Cost
CI, p-value
Locking
6876.74
+755.2
(304.2, 1206.3),
0.01‡
Non-locking
6121.49
Societal (n = 164, CL = 106, PUD = 58)
Plate
Cost*,a
Δ Cost
CI, p-value
Locking
23894.88
-6228.21
(-10549.7, -1906.7), <0.01‡

Table 5: Cost and effect outcomes*.

0.015†
0.017†
0.032†
0.060
0.097
0.137
0.176
0.213
0.246

p-value
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Figure 10: Cost-effectiveness acceptability curves (CEAC) displaying the probability
that the locking plate is cost-effective compared to the non-locking plate from A) the
healthcare payer’s perspective and B) the societal perspective, over a range of
willingness to pay values for an additional one-point improvement in the Knee
injury and Osteoarthritis Outcome Score total change score (baseline to 12
months).
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3.5.3.3

Sensitivity Analysis

Results from our sensitivity analysis suggest that, from the societal perspective,
cost savings are 1) $3309.91, 2) $3747.08 and 3) $3595.41 per one point improvement of
KOOS total change score after adjusting for 1) the dollar value for retired or home
making time at 0$ per hour, 2) time to return to work = time to return to weight bearing
plus seven weeks, and 3) both 1) and 2) (Table 7).
Similarly, the sensitivity analysis provided comparable results when conducting
net benefit regression. In each of the three sensitivity conditions, the INB was positive for
all WTP values indicating that the locking plate is cost-effective compared to non-locking
plate (Table 8). As WTP increases however, the 95% CIs around our estimate widen
suggesting uncertainty in the cost-effectiveness of the locking plate as one is willing to
pay more. Visual display of CEACs indicates that at a WTP of $0, there is between 97%
(Figure 11A) and 99% (Figures 11B and 11C) certainty that the locking plate is costeffective compared to the non-locking plate with a slow decline in certainty as the WTP
increases.
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Table 5: Sensitivity analyses cost and effect outcomes*.
Societal Sensitivity Analysis 1 (n = 164, CL = 106, PUD = 58)
,a
,b
CI, p-value
Δ Effect CI, p-value
Plate
Δ Cost
Cost*
Effect*
Locking
23679.56
-5295.86
(-9873.7, -716.5) ,
21.32
+1.60
(-6.1, 2.9),
0.49
Non-locking
19.72
28975.42
0.02†
Societal Sensitivity Analysis 2 (n = 249, CL = 144, PUD = 105)
,a
,b
CI, p-value
Δ Effect CI, p-value
Plate
Δ Cost
Cost*
Effect*
Locking
24214.74
-5995.32
(-8897.5, -3093.1),
21.32
+1.60
(-6.1, 2.9),
<0.01‡
0.49
Non-locking
30210.06
19.72
Societal Sensitivity Analysis 3 (n = 249, CL = 144, PUD = 105)
,a
,b
CI, p-value
Δ Effect CI, p-value
Plate
Δ Cost
Cost*
Effect*
Locking
24056.14
-5752.66
(-8760.0, -2745.3),
21.32
+1.60
(-6.1, 2.9),
<0.01‡
0.49
Non-locking
29808.81
19.72
*Values are reported as means
a
2016 Canadian dollars.
b
Total change Knee injury and Osteoarthritis Outcome Score (KOOS) between baseline and 12 months
† p < 0.05, ‡ p ≤ 0.001
Abbreviations: ICER = Incremental cost-effectiveness ratio, CI = confidence interval

ICER
-3309.91

ICER
-3747.08

ICER
-3595.41
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Table 6: Sensitivity analyses net benefit regression results.
Societal Sensitivity Analysis 1 (n = 164, CL = 106, PUD = 58)

WTP*
0
250
500
750
1000
1250
1500
1750
2000

Incremental net benefit
4238.26 (2240.09)
4609.59 (2419.84)
4980.91 (2832.09)
5352.24 (3393.11)
5723.56 (4041.43)
6094.89 (4741.36)
6466.22 (5473.14)
6837.54 (6225.55)
7208.87 (6991.93)

95% CI
-186.6 to 8663.1
-170.3 to 9389.5
-613.3 to 10575.1
-1350.1 to 12054.6
-2259.4 to 13706.5
-3270.7 to 15460.4
-4344.8 to 17277.2
-5459.7 to 19134.8
-6602.2 to 21019.9

p-value
0.060
0.059
0.081
0.117
0.159
0.201
0.239
0.274
0.304

Societal Sensitivity Analysis 2 (n = 249, CL = 144, PUD = 105)

WTP*
0
250
500
750
1000
1250
1500
1750
2000

Incremental net benefit
5446.01 (1480.25)
5653.11 (1621.99)
5860.22 (1949.72)
6067.32 (2388.05)
6274.43 (2887.03)
6481.53 (3420.22)
6688.64 (3973.88)
6895.75 (4540.52)
7102.85 (5115.84)

95% CI
2529.9 to 8362.3
2457.8 to 8848.5
2019.3 to 9701.2
1362.8 to 10771.8
586.9 to 11961.9
-256.4 to 13219.5
-1140.0 to 14517.3
-2049.2 to 15840.7
-2975.5 to 17181.2

p-value
<0.001‡
0.001‡
0.003†
0.012†
0.031†
0.059
0.094
0.130
0.166

Societal Sensitivity Analysis 3 (n = 249, CL = 144, PUD = 105)

WTP*
0
250
500
750
1000
1250
1500
1750
2000

Incremental net benefit
5087.07 (1539.42)
5294.18 (1672.44)
5501.28 (1988.74)
5708.39 (2417.42)
5915.50 (2909.23)
6122.60 (3437.16)
6329.71 (3986.90)
6536.81 (4550.55)
6743.92 (5123.52)

95% CI
2054.4 to 8119.8
1999.4 to 8588.9
1583.4 to 9419.1
946.0 to 10470.8
184.3 to 11646.7
-648.7 to 12893.9
-1524.6 to 14184.0
-2427.8 to 15501.5
-3349.5 to 16837.4

p-value
0.001‡
0.002†
0.006†
0.019†
0.043†
0.076
0.114
0.152
0.189

* WTP for a one-point improvement on the KOOS total change score from baseline to 12 months
** Incremental net benefit with standard error (SE)
a
A positive incremental net benefit favors the locking plate treatment group
† p < 0.05, ‡ p ≤ 0.001
Abbreviations: WTP = willingness-to-pay, CI = confidence interval
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Figure 11: Sensitivity analysis cost-effectiveness acceptability curves (CEAC)
displaying the probability that the locking plate is cost-effective compared to the
non-locking plate from the societal perspective over a range of willingness to pay
values for an additional one-point improvement in the Knee injury and
Osteoarthritis Outcome Score total change score (baseline to 12 months). A)
Adjusting the dollar value for retirement or home making time, B) Adjusting the
time to return to work, C) Combining the two previous adjustments.
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Chapter 4

4

Discussion

The present study is the first to investigate the clinical and cost-effectiveness of a locking
plate compared to a non-locking plate in patients undergoing medial opening wedge
HTO. We found statistically significant differences in time to return to full weightbearing favoring the locking plate group, while there were no statistically significant
differences in the KOOS total change score or any of its subdomains from baseline to six
months between the two plate groups. Our results also suggest that the locking plate is
unlikely to be cost-effective from the healthcare payer perspective, although it may be
cost-effective from the societal perspective.
With the suggested additional stability that the locking plate provides, we expected these
patients to return to full weight-bearing much faster than patients who received the nonlocking plate. In line with our hypothesis, we found that patients who underwent HTO
with the locking plate returned to full weight-bearing without gait aid use at a mean 10.9
± 5.8 weeks after surgery, which was significantly sooner than patients receiving the
locking plate whose return to full weight-bearing time was 17 ± 6.5 weeks (between
group difference = 6.1 weeks, 95% CI 4.5, 7.6). The present findings are in line with
those from Asik et al. who report return to full weight-bearing times of approximately
three months after surgery among 65 patients who received a non-locking plate24.
Reports in the literature for time to return to full weight-bearing in locking plates vary
considerably. Lobenhoffer and Agneskirchner reported that patients who received a
locking plate (Synthes TomoFix Plate®) began full weight-bearing as early as six to nine
weeks postoperative, however it is unclear whether this was with complete
discontinuation of crutch use or if the patient was able to put full weight on the operative
limb with assisted crutch use177. Staubli et al. reported that patients returned to full
weight-bearing without crutches at ten weeks after surgery on average when using a
locking plate (Synthes TomoFix Plate®)178, while Brosset et al. reported a mean 3
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months to return to full weight-bearing without gait aid assistance among 51 patients
using the same locking plate39.
Hernigou et al. also compared patients receiving locking and non-locking HTO plates
(Limmed Plate®). They found that 80% of patients began full weight-bearing on the
operative limb without crutches at a mere two weeks following the HTO when locking
screws were used (n = 85), while matched control patients who received non-locking
screws (n = 85) took three months to return to full weight-bearing. However, their patient
sample is considered a healthy weight (BMI between 20 and 25 kg/m2)37, whereas our
patient sample is considered borderline obese (BMI ≈ 30 kg/m2). It is therefore difficult
to compare our results with the results from Hernigou et al. as previous studies have
emphasized the importance of handling the rehabilitation process after HTO in obese
patients with care due to a longer period time required for healing129,179,180.
A recent study from Landsdaal et al. investigated the functional impacts of early weightbearing for patients undergoing medial opening wedge HTO with a locking HTO plate
(Synthes TomoFix Plate®) in a randomized control trial30. They found that although
patients were able to immediately begin weight-bearing (45 days earlier than their
delayed weight-bearing group), 29% of patients in the immediate weight-bearing group
(n = 25) were still using crutches at three months compared to only 17% of the delayed
weight-bearing group patients (n = 25). This suggests that goals should perhaps not be
aimed at allowing patients to immediately begin weight-bearing after HTO surgery, but
instead identifying the optimal time period to begin the weight-bearing process that
promotes bone healing in a safe manner.
A primary concern for surgeons in allowing patients an early return to full weight-bearing
without crutches is the risk of post-operative complications. However, we found that
despite a much faster return to full weight-bearing for the locking plate patients, postoperative complications were generally similar between the two groups aside from
hardware failures which occurred slightly more frequently in patients receiving the nonlocking plate. This is likely because of the lack of primary stability that the non-locking
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plate provides with excess motion to the osteotomy site and increased stress on the plate
and screws33,35. Although we expected to see higher rates of plate removal in the locking
plate group, the number of cases between groups is similar. It is important to note
however, that plate removals were only reported up to 12 months following the HTO to
be included in our cost-effectiveness analysis.
Based on the suggested quicker return to full weight-bearing with the locking plate, we
expected to see earlier improvements in patient-reported outcomes in these patients when
compared to those receiving the non-locking plate. Although the KOOS total and
subdomain change scores are slightly higher in the locking plate group from baseline to
six months after surgery, the between-group differences are not statistically significant.
No other studies have compared KOOS scores between the locking plate and non-locking
plate, however the large improvements in KOOS seen for both treatment groups from
baseline to six months after the surgery is similar to results found in the literature.
Brinkman et al. found significant improvements for early weight-bearing patients when
using a locking plate (Synthes TomoFix Plate®, n = 14), with a change score ranging
between 8 and 35 points from baseline to six months in individual KOOS subdomains27.
Birmingham et al. also found significant improvements in all KOOS domains from
baseline to six months when using a non-locking plate (Arthrex Puddu Plate®, n = 126),
although the six month KOOS score mean values were not reported (primary outcomes
were 24-month data)122.
Results from our CEA suggest that the use of a locking plate for fixation in medial
opening wedge HTO is unlikely to be cost-effective from the healthcare payer
perspective, although it may be cost-effective from the societal perspective. In terms of
effectiveness, we found statistical uncertainty surrounding the small difference in
improvement seen in the KOOS total change score that favors the locking plate group
(+1.60 KOOS total change point; 95% CI -6.1, 2.9) indicating that either intervention
could be the favorable treatment. Therefore, our results are driven heavily by differences
in costs between the two interventions.
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In our sample, we found that the initial surgical costs are very similar between groups
with similar rates of postoperative complications requiring additional intervention (i.e.
revision surgery, etc.). The difference in overall cost between the two interventions
(+$755.20 for the locking plate) is reflected in the raw plate and screw costs ($1,192.43
for the non-locking plate (Arthrex Puddu Plate®) and $1,827.43 for the locking plate
(Arthrex ContourLock HTO Plate®)). The ICER value of +$472.00 per one additional
point improvement in the KOOS total change score suggests that the Ministry of Health
must be willing to pay almost $5,000 more per patient to achieve a clinically important
improvement in KOOS score, however due to the similar outcomes between groups, it is
unlikely to be cost-effective. This is further supported with the results from the NBR
(Table 6) and the CEAC (Figure 10A) which show that the probability that the locking
plate is cost-effective from the payer perspective plateaus at around 55% at a WTP of
$1,000 (Figure 10A) with probabilities less than half of that when WTP < $1,000, making
the non-locking plate a more attractive treatment option for institutional decision makers
in terms of saving healthcare dollars.
On the other hand, we did find the locking plate to be cost-effective from the societal
perspective, which incorporates indirect costs such as time off work, retirement and home
making and out-of-pocket expenses for the patient. The difference in overall societal
costs between treatment groups favored the locking plate with an estimated $6,228.21
cost saving at 12 months following the HTO. The cost difference is largely due to a much
sooner time to return to employment/activities and reduction in productivity losses for
patients receiving the locking plate. These conclusions are supported from our NBR
model (Table 6) and CEAC (Figure 10B) which suggest that there is a 99% probability
that the locking plate is cost-effective at a WTP of $0, however this certainty slowly
decreases as the WTP value increases (Figure 10B). This is explained by the uncertainty
surrounding the incremental effect between the two treatment groups. The wide
confidence intervals around our estimated incremental effect (95% CI -6.1, 2.9) indicate
that using the locking plate does not always result in health gains and therefore, the
CEAC is a slowly decreasing function of WTP181.
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Both perspectives provide valuable information in the process of decision-making. A few
essential aspects specific to HTO are worth considering when making decisions. The
rehabilitation period after HTO surgery is deemed fairly lengthy with a period of crutch
ambulation that can continue several weeks after surgery as evidenced by numerous
studies in the literature24,30,39,177,178 and results from our study (Table 3). Consequently,
employed patients are often off work for extended periods of time and retired and home
making patients are often limited in their everyday activities for many weeks which can
generate large losses in productivity for society.
The viewpoint of institutional decision makers is often quite restrictive to direct system
costs and sometimes fails to consider the overall societal impacts. From our results, the
decision maker may opt for using the non-locking plate due to significantly lower cost;
however considering solely the healthcare payer perspective could significantly
undermine the true benefit the locking plate for society. Ignoring these important costs in
CEA can lead to inefficient allocation of resources both short and long-term for society as
a whole182. The societal perspective theoretically includes all costs relating directly to the
patient, their families, the public, and government expenditures as a whole, making for a
more comprehensive analysis. Although much attention is given to the direct healthcare
costs associated with OA in current economic analyses, workforce absenteeism has been
shown to contribute considerably to the burden of OA in Canada182. One study estimated
that 80% of the overall annual costs for OA result from time lost from employment and
leisure by both participants and unpaid caregivers143. Therefore, it is important for
decision makers to consider the entire scope of incurred costs when allocating resources.
It is important to consider both perspectives for decision making, however most
organizations such as The Canadian Agency for Drugs and Technologies in Health
advocate that the societal perspective holds the most importance for the entire
population’s best interest160.
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Our center performs approximately 75 to 100 HTO surgeries annually. In the eyes of the
healthcare payer, using the non-locking (Arthrex Puddu Plate®) for HTO could save
$755.20 for every patient (equivalent to approximately $56,500 cost saving annually).
When examining from a societal perspective, the costs associated with using the locking
(Arthrex ContourLock HTO Plate®) over the non-locking plate are offset by significant
savings to society (equivalent to approximately $467,000 cost saving annually).
Ultimately, it may require surgeons to advocate the use of socioeconomically favorable
treatment interventions and offer perspective to governing boards who remain restrictive
in the decision-making process. Potential solutions include the reallocation of funds for
surgical equipment to offset the higher cost of locking plates and profit from its societal
cost savings, benefiting from both perspectives. For example, bone graft and substitutes
cost between $500 and $750 per HTO procedure. Recent evidence suggests that the use
bone graft or substitutes may be unnecessary when using a stronger locking plates as
patients experience similar improvements in clinical outcomes without an increase in
complication rates125. Eliminating the cost of graft could offset the higher cost of the
locking plate designs; however this is a question that demands further research.

4.1 Strengths & Limitations
To our knowledge, our study is the first to investigate clinical outcomes for the Arthrex
ContourLock HTO Plate® and also the first to compare the cost-effectiveness of plate
design in medial opening wedge HTO. The strengths of this study include the use of
validated disease/joint specific outcomes and a large sample size. Furthermore, the use of
the net benefit regression framework in our CEA allowed us to control for baseline
variables and to explore potential interaction terms for a richer understanding of the costeffectiveness, which can be limited when solely exploring incremental cost-effectiveness
ratios173.
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Perhaps the biggest limitation in our study was the retrospective design. The decision to
use a locking vs. non-locking plate resulted from a shift in clinical practice. The lack of
group randomization makes our study susceptible to biases that could factor into patient
improvement after surgery as a result of between-group differences in baseline
characteristics. However, baseline demographic and clinical characteristics that were
believed to influence outcomes in this study are similar between groups and were also
controlled for in our cost-effectiveness analysis.
Slight between-group differences are seen in the degree of joint degeneration in the
lateral compartment of the knee (more severe for the locking plate group). There are also
between-group differences in the number of concomitant tibial tubercle osteotomy
surgeries performed (more in the locking group), the number of outpatient procedures
(more in the locking group) and the number of osteotomies that were left unfilled, with
no bone graft (more in the non-locking group). For these characteristics, time was likely a
factor contributing to between-group differences as a result of the shift in clinical
practice. Differences in lateral compartment degeneration could have resulted from
differences in measurement between radiographic assessors or surgeon expertise over
time treating more advance OA cases. Differences in the number of TTOs, outpatient
procedures performed and osteotomy gaps left unfilled could have resulted from changes
in medical practice over time. However, these clinical and surgical characteristics are not
thought to have influenced the outcomes investigated in this study.
Another large limitation in our study is the high volume of assumptions that were made
when assessing patient charts such as identifying the exact time to return to full weightbearing without crutches. Although data extraction methods were standardized for the
two treatment groups, data collected prospectively (i.e. through questionnaires) may have
been more precise. Prospective data collection would have also allowed us to address
other relevant questions such as patient satisfaction following the surgery (i.e. related to
return to weight-bearing rehabilitation process).

70

Further, patients who filled out cost questionnaires in our study were asked to recall how
long they were off work after surgery, making our data susceptible to recall bias. To
minimize this, response options were presented in 2-month increments (i.e. 3-4 months).
Another limitation to our study is that all surgeries were performed by a single surgeon.
This presents the risk for expertise bias that could influence interpretation of bone
consolidation and pain in deciding whether to allow the patient to begin full weightbearing. Additionally, complication rates from our study are low when compared to
previous studies24,126,134–139. The surgeon’s expertise could have resulted in the lower
complication rate from years of experience performing HTO procedures, which threatens
the external validity (generalizability) of the results to other clinical practices.
Specifically, the frequency of hardware removals reported for patients receiving a locking
plate are quite low when compared to previous studies who report over 80% removal
rate29,40. Although we were unable to control for this in our cost-effectiveness analysis
that uses trial-based data, alternative model-based analyses can use complication and
plate removal rates reported in the literature to generate cost estimates.
The generalizability of this study is also threatened by the fact that all surgeries were
performed at a single center. For example, our center receives a pro-rate on charges for
some surgical equipment costs due to the high volume of HTO cases performed annually,
which may not translate to costing at other centers. It is important also to note that this
study was designed to evaluate the clinical and cost-effectiveness of using the Arthrex
ContourLock HTO Plate® (locking) over the Arthrex Puddu Plate® (non-locking) for
medial opening wedge HTO in patients with medial compartment knee OA and varus
alignment and therefore conclusions should not be drawn for patients receiving variations
of the osteotomy procedure (i.e. lateral closing wedge HTO, distal femoral osteotomy,
etc.), who are valgus aligned or undergo HTO using a different internal fixation plate.
Another potential limitation for this study is the 12-month follow-up period. Previous
studies have indicated that the survivorship of a HTO can exceed 15 years130 and the
optimal economic analysis would incorporate all lifetime costing159 which includes
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revision and co-interventions past the 12 month mark (i.e. revision HTO, conversion to
TKA or UKA, etc.). However, the likelihood that large differences in cost exist between a
locking plate and non-locking plate past the 12 month mark is low since the majority of
post-operative complications occur within the first 12 months of surgery, as does the
progression to full weight-bearing28,30,36,126,179.
Finally, some costs typically included in CEAs to capture a more comprehensive societal
perspective were omitted due to the retrospective nature of the study. Direct costs related
to out-of-pocket expenses for the patient/caregivers and over-the-counter
medication/aids, as well as indirect costs related to time lost from the caregiver were not
available to be included in the study. Therefore, our total cost values are likely
underestimated. However, we suspect that addition of these costs would increase the cost
difference between groups as a result of a much quicker return to full weight-bearing for
the locking plate group. Our estimate is therefore conservative.
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5

Conclusion

We found that patients who received a locking plate (Arthrex ContourLock HTO Plate®)
for medial opening wedge HTO returned to full weight-bearing without assistance of gait
aid significantly faster than patients who received a non-locking plate (Arthrex Puddu
Plate®). No significant between-group differences were found for the change in KOOS
from baseline to six months after surgery. Results from our CEA indicate that the locking
plate is not cost-effective from the healthcare payer’s perspective as a result of higher
initial plate and screw costs. The locking plate is however, cost-effective from the
societal perspective as patients return to work much faster after the surgery.

5.1 Future Directions
The retrospective nature of this study required a high volume of assumptions to be made
during data extraction, opening the opportunity for improved study design in future
investigations. Prospective studies should aim to introduce more surgeons and
orthopaedic centers to make results from this study (i.e. complication rates, cost, etc.)
more generalizable to all medial opening wedge HTO procedures while including various
different locking and non-locking plate designs. Time to return to weight-bearing and
time to return to work should be collected prospectively, along with direct patient costs,
caregiver costs and other out-of-pocket expenses that would generate a more complete
CEA estimate.
Results from this study indicate that the locking plate allows patients to return to full
weight-bearing much quicker after HTO. It would therefore be important to evaluate
patient outcomes (i.e. change in muscle strength, functional outcomes, etc.) at shorter
follow-up times (i.e. 3 months) to observe if the differences in return to full weightbearing time could also affect the rate of improvement in patient activities of daily living,
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quality of life and gait mechanics. Finally, studies should be conducted to determine
whether costs can be minimized when eliminating bone graft or substitute in HTO
procedures when a locking plate is used, as some studies have suggested that bone graft is
not necessary for these cases125. In turn, we could benefit from both the healthcare and
societal viewpoints of cost when using a locking plate.
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